What is Aurinia Pharmaceuticals's net debt / EBITDA?

Aurinia Pharmaceuticals (AUPH) reported net debt / EBITDA of 0.3× in Q1 2026.

How has Aurinia Pharmaceuticals's net debt / EBITDA changed year-over-year?

Aurinia Pharmaceuticals's net debt / EBITDA decreased by 41.1% year-over-year, from 0.5× to 0.3×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Aurinia Pharmaceuticals AUPH Net debt / EBITDA

Net debt / EBITDA at other companies

Rogers CorporationROG

-193.9×-195×

ANI PharmaceuticalsANIP

-0×-2.5×

Kiniksa Pharmaceuticals International, plcKNSA

-1.9×—

Arrowhead ResearchARWR

-0.3×—

Mirum Pharmaceuticals, Inc.MIRM

-116.1×—

ALN

Alnylam PharmaceuticalsALNY

-1.8×—

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

net debt/ebitda=0.3×

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's net debt / EBITDA?: Aurinia Pharmaceuticals (AUPH) reported net debt / EBITDA of 0.3× in Q1 2026.
How has Aurinia Pharmaceuticals's net debt / EBITDA changed year-over-year?: Aurinia Pharmaceuticals's net debt / EBITDA decreased by 41.1% year-over-year, from 0.5× to 0.3×.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.